Comerica Bank Has $2.64 Million Stock Holdings in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)

Comerica Bank lessened its position in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 7.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 166,560 shares of the software maker’s stock after selling 12,987 shares during the quarter. Comerica Bank owned approximately 0.13% of Allscripts Healthcare Solutions worth $2,640,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Eaton Vance Management acquired a new position in shares of Allscripts Healthcare Solutions during the 1st quarter worth approximately $30,000. Dark Forest Capital Management LP acquired a new position in shares of Allscripts Healthcare Solutions during the 2nd quarter worth approximately $89,000. Tocqueville Asset Management L.P. acquired a new position in shares of Allscripts Healthcare Solutions during the 2nd quarter worth approximately $186,000. XTX Topco Ltd acquired a new position in shares of Allscripts Healthcare Solutions during the 2nd quarter worth approximately $219,000. Finally, LMR Partners LLP acquired a new position in shares of Allscripts Healthcare Solutions during the 2nd quarter worth approximately $223,000. 96.40% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have weighed in on MDRX. Canaccord Genuity boosted their price target on Allscripts Healthcare Solutions from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Monday, November 8th. SVB Leerink boosted their price target on Allscripts Healthcare Solutions from $17.00 to $19.00 and gave the stock a “market perform” rating in a research report on Friday, August 6th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Allscripts Healthcare Solutions in a research report on Friday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on Allscripts Healthcare Solutions from $18.00 to $20.00 and gave the stock a “hold” rating in a research note on Tuesday. Finally, Piper Sandler reiterated a “neutral” rating and set a $17.00 target price (up from $15.00) on shares of Allscripts Healthcare Solutions in a research note on Friday, August 6th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $18.79.

Shares of NASDAQ MDRX opened at $17.35 on Thursday. The stock has a 50 day moving average of $14.53 and a 200-day moving average of $16.16. The company has a market capitalization of $2.13 billion, a P/E ratio of 3.37, a P/E/G ratio of 2.68 and a beta of 1.04. Allscripts Healthcare Solutions, Inc. has a 12 month low of $13.05 and a 12 month high of $19.00. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.26.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings results on Thursday, November 4th. The software maker reported $0.27 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.18 by $0.09. The business had revenue of $369.00 million during the quarter, compared to the consensus estimate of $376.09 million. Allscripts Healthcare Solutions had a return on equity of 6.98% and a net margin of 51.74%. The firm’s quarterly revenue was down 8.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.15 EPS. Analysts predict that Allscripts Healthcare Solutions, Inc. will post 0.65 EPS for the current fiscal year.

In other news, Director Greg Garrison sold 77,381 shares of the company’s stock in a transaction on Tuesday, September 7th. The stock was sold at an average price of $15.02, for a total transaction of $1,162,262.62. Following the completion of the sale, the director now directly owns 47,813 shares in the company, valued at approximately $718,151.26. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Richard J. Poulton sold 10,000 shares of the company’s stock in a transaction on Monday, November 15th. The shares were sold at an average price of $16.38, for a total value of $163,800.00. The disclosure for this sale can be found here. Insiders own 1.91% of the company’s stock.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segment. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units.

Featured Story: Overbought

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.